AIDS Walk 2016

June 9, 2016

Help us raise $5,000 for critical HIV services!

Women make up 1 in 4 new HIV infections in the Bay Area. On July 17th, we will be walking in San Francisco’s AIDS Walk to raise awareness and funds for HIV/AIDS testing, treatment, prevention, education and advocacy.

We are part of a unique community partnership: this means that 80% of the money we raise will be given back to the Clinic to support the HIV/AIDS-related services we provide to low-income women!

Women need HIV resources that are accessible, culturally appropriate, and centered on each woman as an individual. Join our team, sponsor a walker, or make a general team donation at our AIDS Walk website:

What HIV-related services does Women’s Community Clinic provide?
The Clinic recognizes that HIV testing and education are critical components of comprehensive health care for all women, and has fully integrated these services into the care we provide, both at our Clinic and through our Outreach and Community programs.

We serve the most vulnerable populations
Low-income women, women of color, and younger women are at the highest risk for HIV infection. Approximately 90% of Clinic clients live at or below $25,000 per year, 40-60% are women of color, and 30% are between the ages of 12-24. Clinic services are available to all women regardless of ability to pay, and care is rooted in philosophies of client-centeredness, harm reduction, and cultural inclusion. These practices break down social, cultural, and economic barriers that often prevent women from accessing critical health services.

We educate, inform, and counsel
The Clinic offers comprehensive information about HIV to each client, identifying her individual risk factors and offering risk reduction options tailored to her specific needs. In 2015, the Clinic offered in-house health education and clinical services, including HIV risk assessment and education as needed, to 3,016 Bay Area women and girls. We conducted 914 rapid HIV tests and HIV specific counseling sessions for women for whom testing was clinically indicated.